Docality.com Logo
 
Dr. Irene  Moy  Md image

Dr. Irene Moy Md

250 E Superior St
Chicago IL 60611
312 724-4673
Medical School: Other - Unknown
Accepts Medicare: No
Participates In eRX: No
Participates In PQRS: No
Participates In EHR: No
License #:
NPI: 1487839791
Taxonomy Codes:
207V00000X

Request Appointment Information

Awards & Recognitions

About Us

Practice Philosophy

Conditions

Medical Malpractice Cases

None Found

Medical Board Sanctions

None Found

Referrals

None Found

Publications

Fertility-preserving management of a uterine arteriovenous malformation: a case report of uterine artery embolization (UAE) followed by laparoscopic resection. - Journal of minimally invasive gynecology
Herein is presented a fertility-preserving approach in the management of a uterine arteriovenous malformation (AVM) resistant to endovascular management. The patient had a documented AVM and underwent 2 uterine artery embolization procedures, with subsequent recurrence of symptoms. Doppler ultrasound demonstrated recanalization of the AVM. Ultimately, laparoscopic resection of the AVM was performed after laparoscopic ligation of the uterine arteries. Postoperatively, the patient has remained asymptomatic. Laparoscopic resection of a uterine AVM may offer a fertility-preserving alternative to hysterectomy in patients in whom endovascular management has failed.Published by Elsevier Inc.
Expression of estrogen-related gene markers in breast cancer tissue predicts aromatase inhibitor responsiveness. - PloS one
Aromatase inhibitors (AIs) are the most effective class of drugs in the endocrine treatment of breast cancer, with an approximate 50% treatment response rate. Our objective was to determine whether intratumoral expression levels of estrogen-related genes are predictive of AI responsiveness in postmenopausal women with breast cancer. Primary breast carcinomas were obtained from 112 women who received AI therapy after failing adjuvant tamoxifen therapy and developing recurrent breast cancer. Tumor ERα and PR protein expression were analyzed by immunohistochemistry (IHC). Messenger RNA (mRNA) levels of 5 estrogen-related genes-AKR1C3, aromatase, ERα, and 2 estradiol/ERα target genes, BRCA1 and PR-were measured by real-time PCR. Tumor protein and mRNA levels were compared with breast cancer progression rates to determine predictive accuracy. Responsiveness to AI therapy-defined as the combined complete response, partial response, and stable disease rates for at least 6 months-was 51%; rates were 56% in ERα-IHC-positive and 14% in ERα-IHC-negative tumors. Levels of ERα, PR, or BRCA1 mRNA were independently predictive for responsiveness to AI. In cross-validated analyses, a combined measurement of tumor ERα and PR mRNA levels yielded a more superior specificity (36%) and identical sensitivity (96%) to the current clinical practice (ERα/PR-IHC). In patients with ERα/PR-IHC-negative tumors, analysis of mRNA expression revealed either non-significant trends or statistically significant positive predictive values for AI responsiveness. In conclusion, expression levels of estrogen-related mRNAs are predictive for AI responsiveness in postmenopausal women with breast cancer, and mRNA expression analysis may improve patient selection.
Aromatase, breast cancer and obesity: a complex interaction. - Trends in endocrinology and metabolism: TEM
Obesity has been associated with abnormally high expression of the enzyme aromatase in the breast, increased local estrogen production, and predisposition to breast hyperplasia and cancer. Increased adiposity in postmenopausal women may trigger signaling pathways that induce aromatase expression. In breast adipose fibroblasts, increased TNF production may induce the distal aromatase promoter, whereas increased local PGE(2) production may induce the proximal promoter region. We review here the mechanisms that control aromatase gene expression in breast adipose tissue, and the paracrine interactions between malignant breast epithelial cells and the surrounding adipose fibroblasts. Systematic characterization of these signaling pathways will facilitate the identification of potential drug targets to selectively reduce aromatase expression and excessive estrogen production, with therapeutic benefit.Copyright © 2011 Elsevier Ltd. All rights reserved.
Randomized controlled trial: effects of acupuncture on pregnancy rates in women undergoing in vitro fertilization. - Fertility and sterility
To evaluate the influence of "true" versus "sham" acupuncture on pregnancy rates (PRs) in women undergoing IVF.Randomized controlled trial, double-blinded with independent observer.Academic infertility clinic.One hundred sixty patients <38 years old undergoing IVF with or without intracytoplasmic sperm injection.Subjects were randomly allocated to the true or sham group and underwent acupuncture 25 minutes before and after ET. Subjects completed a McGill Pain Questionnaire regarding their clinical symptoms during ET.Clinical PR and clinical symptoms during ET.While the overall clinical PR was 51.25%, there was no significant difference between the arms of the study (true = 45.3% vs. sham = 52.7%); 33.1% of the patients had ultrasound-documented singleton pregnancy, and 15% of patients had twin gestations, while one patient in the true arm had a triplet gestation. There were significant differences in the subjective, affective, and total pain experience between both arms. The subjects in the true arm described their acupuncture session as being more "tiring" and "fearful" and experienced more "achiness" compared with their sham counterparts.There was no statistically significant difference in the clinical or chemical PRs between both groups. Patients undergoing true acupuncture had differing sensory experiences compared with patients in the sham arm. There were no significant adverse effects observed during the study, suggesting that acupuncture is safe for women undergoing ET.Copyright © 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Map & Directions

250 E Superior St Chicago, IL 60611
View Directions In Google Maps

Nearby Doctors

225 E Chicago Ave Neurosurgery
Chicago, IL 60611
312 274-4220
737 N Michigan Ave Suite 2240
Chicago, IL 60611
312 550-0140
737 N Michigan Ave Suite 2130
Chicago, IL 60611
312 401-1709
233 E Erie St
Chicago, IL 60611
312 370-0374
225 E Chicago Ave Box 24
Chicago, IL 60611
312 276-6340
251 E Huron St Galter 3-150
Chicago, IL 60611
312 262-2253
251 E Huron St Galter 3-150
Chicago, IL 60611
312 262-2253
251 E Huron St Feinberg 4-741G
Chicago, IL 60611
312 264-4415
250 E Superior St
Chicago, IL 60611
312 723-3970
251 E Huron St F5-704
Chicago, IL 60611
312 268-8132